These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 23610963

  • 21. Changes in gene expression induced by phosphorothioate oligodeoxynucleotides (including G3139) in PC3 prostate carcinoma cells are recapitulated at least in part by treatment with interferon-beta and -gamma.
    Benimetskaya L, Wittenberger T, Stein CA, Hofmann HP, Weller C, Lai JC, Miller P, Gekeler V.
    Clin Cancer Res; 2004 Jun 01; 10(11):3678-88. PubMed ID: 15173074
    [Abstract] [Full Text] [Related]

  • 22. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP.
    J Natl Cancer Inst; 2007 Jul 18; 99(14):1107-19. PubMed ID: 17623797
    [Abstract] [Full Text] [Related]

  • 23. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.
    Buck AC, Shen C, Schirrmeister H, Schmid-Kotsas A, Munzert G, Guhlmann A, Mehrke G, Klug N, Gross HJ, Bachem M, Reske SN.
    Cancer Biother Radiopharm; 2002 Jun 18; 17(3):281-9. PubMed ID: 12136520
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
    Abdel-Mageed A, Agrawal KC.
    Cancer Gene Ther; 1997 Jun 18; 4(3):199-207. PubMed ID: 9171939
    [Abstract] [Full Text] [Related]

  • 27. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of compound Rhizoma Smilacinus granules on the expression of Bcl-2 and Bax gene in A549 cell lines of non-small cell lung cancers].
    Li GC, Dong KL, Hu CH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr 01; 32(2):312-5. PubMed ID: 17478943
    [Abstract] [Full Text] [Related]

  • 30. Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.
    Lo YL, Liu Y.
    PLoS One; 2014 Apr 01; 9(3):e90180. PubMed ID: 24637737
    [Abstract] [Full Text] [Related]

  • 31. [Effects of bcl-2 antisense oligodeoxynucleotide on proliferation and apoptosis of Raji cells].
    Wang FX, Dong ZR, Liu ZL, Zhang XJ, Yao L, Yang JC, Du XY.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb 01; 24(2):71-3. PubMed ID: 12697099
    [Abstract] [Full Text] [Related]

  • 32. Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway.
    Chang MC, Chen CA, Hsieh CY, Lee CN, Su YN, Hu YH, Cheng WF.
    Biochem J; 2009 Dec 10; 424(3):449-58. PubMed ID: 19747165
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of Bcl-2 enhances the efficacy of epirubicin chemotherapy in PC-3 prostate cancer cells.
    Jiang H, Xia D, Wu LJ, Chen ZD.
    Chin Med J (Engl); 2011 Dec 10; 124(23):4018-21. PubMed ID: 22340335
    [Abstract] [Full Text] [Related]

  • 34. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
    Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T.
    Cancer Res; 1998 Aug 01; 58(15):3331-8. PubMed ID: 9699663
    [Abstract] [Full Text] [Related]

  • 35. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
    Zhang C, Pei J, Kumar D, Sakabe I, Boudreau HE, Gokhale PC, Kasid UN.
    Methods Mol Biol; 2007 Aug 01; 361():163-85. PubMed ID: 17172711
    [Abstract] [Full Text] [Related]

  • 36. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
    Lebedeva I, Rando R, Ojwang J, Cossum P, Stein CA.
    Cancer Res; 2000 Nov 01; 60(21):6052-60. PubMed ID: 11085527
    [Abstract] [Full Text] [Related]

  • 37. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides.
    Miayake H, Tolcher A, Gleave ME.
    J Natl Cancer Inst; 2000 Jan 05; 92(1):34-41. PubMed ID: 10620631
    [Abstract] [Full Text] [Related]

  • 38. Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin.
    Elliott MJ, Stribinskiene L, Lock RB.
    Cancer Chemother Pharmacol; 1998 Jan 05; 41(6):457-63. PubMed ID: 9554589
    [Abstract] [Full Text] [Related]

  • 39. Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells.
    Fukumi S, Horiguchi-Yamada J, Nakada S, Nagai M, Ohno T, Yamada H.
    Mol Cell Biochem; 2000 Mar 05; 206(1-2):43-50. PubMed ID: 10839193
    [Abstract] [Full Text] [Related]

  • 40. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
    Taylor ST, Hickman JA, Dive C.
    J Natl Cancer Inst; 2000 Jan 05; 92(1):18-23. PubMed ID: 10620629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.